Application 209057
- Type
- ANDA
- Sponsor
- CROSSMEDIKA SA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | TABLET;ORAL | 2.5MG | No | No |
| 002 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | TABLET;ORAL | 5MG | No | No |
| 003 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | TABLET;ORAL | 10MG | No | No |
| 004 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | TABLET;ORAL | 20MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209057-001 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2018-10-31 | |
| A209057-002 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2018-10-31 | |
| A209057-003 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2018-10-31 | |
| A209057-004 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2018-10-31 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209057-001 | AB |
| A209057-002 | AB |
| A209057-003 | AB |
| A209057-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209057-001 | VARDENAFIL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2018-10-31 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209057-002 | VARDENAFIL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2018-10-31 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209057-003 | VARDENAFIL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2018-10-31 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209057-004 | VARDENAFIL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2018-10-31 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209057-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209057-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209057-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209057-004 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vardenafil Hydrochloride | VARDENAFIL HYDROCHLORIDE | Lannett Company, Inc. | 2782efed-6198-47b9-81ac-3e255e2ab7f6 | 2026-07-15 | Warnings, Adverse reactions | 209057 ANDA209057 0527-2800 0527-2803 0527-2801 0527-2802 |
| Vardenafil Hydrochloride | VARDENAFIL HYDROCHLORIDE | AvKARE | 80c4793d-e19e-10f0-e053-2991aa0a4620 | 2026-01-15 | Warnings, Adverse reactions | 209057 ANDA209057 42291-848 42291-847 |
| Vardenafil Hydrochloride | VARDENAFIL HYDROCHLORIDE | Chartwell RX, LLC | 57a0c163-a5e8-4c6e-a4ea-114cb2668407 | 2025-12-10 | Warnings, Adverse reactions | 209057 ANDA209057 |
| Vardenafil Hydrochloride | VARDENAFIL HYDROCHLORIDE | Bryant Ranch Prepack | 083a3282-254f-4042-b0eb-70f76a279f10 | 2025-11-06 | Warnings, Adverse reactions | 209057 ANDA209057 |
| Vardenafil Hydrochloride | VARDENAFIL HYDROCHLORIDE | Bryant Ranch Prepack | 6d2859a7-6def-455f-856b-9db86b1fd355 | 2025-11-06 | Warnings, Adverse reactions | 209057 ANDA209057 |
| Vardenafil Hydrochloride | VARDENAFIL HYDROCHLORIDE | Bryant Ranch Prepack | 666a622b-2464-4c55-8c90-0f1cc85bc1e9 | 2025-10-28 | Warnings, Adverse reactions | 209057 ANDA209057 |
| Vardenafil Hydrochloride | VARDENAFIL HYDROCHLORIDE | Bryant Ranch Prepack | 8791997d-3b86-45af-988f-808e259da506 | 2025-10-28 | Warnings, Adverse reactions | 209057 ANDA209057 |
| Vardenafil Hydrochloride | VARDENAFIL HYDROCHLORIDE | AvKARE | 3b03952b-d404-09cd-e063-6294a90a8b2c | 2025-07-28 | Warnings, Adverse reactions | 209057 ANDA209057 |
| Vardenafil Hydrochloride | VARDENAFIL HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 09366eb3-93e0-41d9-bf9a-24335ed3555f | 2021-01-27 | Warnings, Adverse reactions | 209057 ANDA209057 71610-508 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0527-2800 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-2800 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-2800 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-2800 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-2801 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-2801 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-2801 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-2801 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-2802 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-2802 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-2802 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-2802 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-2803 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-2803 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-2803 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-2803 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 42291-847 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | AvKARE, Inc. | ANDA | Current |
| 42291-847 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | AvKARE | ANDA | Current |
| 42291-847 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | AvKARE | ANDA | Current |
| 42291-848 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | AvKARE, Inc. | ANDA | Current |
| 42291-848 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | AvKARE | ANDA | Current |
| 42291-848 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | AvKARE | ANDA | Current |
| 71610-310 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 71610-508 | Vardenafil Hydrochloride | Vardenafil Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |